Setting 
My Cart
Toggle Nav
Close
  • Menu
  • Setting

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Catalog No.
R1011
EGFP mRNA with Cap 1 structure, modified by 5-moUTP and Cy5-utp, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation
Grouped product items
SizePriceStock Qty
100ug (1mg/mL)
$294.00
In stock
1mg (1mg/mL)
$1,590.00
In stock
5x1mg (1mg/mL)
$5,727.00
In stock
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

EZ Cap™ Cy5 EGFP mRNA (5-moUTP) is a superior dual-fluorescence reporter tool engineered for advanced gene delivery research and real-time analysis. This product integrates the tracking capability of Cy5 with the functional reporting of EGFP protein expression, providing a ready-to-use tool for validating and optimizing delivery systems. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) is widely used in macrophage-targeted therapy development, nanoparticle validation, and quantitative transfection studies.

Key features:

Fluorescent Labeling: The mRNA is covalently conjugated with Cy5 dye, enabling direct visualization of mRNA delivery, cellular uptake, and intracellular trafficking using fluorescence microscopy or flow cytometry, without the need for secondary detection steps.

Cap1 Structure: The mRNA incorporates a Cap1 analog at the 5' end, ensuring high translation initiation efficiency, improved stability, and reduced innate immune recognition, leading to stronger and more sustained luciferase expression.

Modified Nucleotides: It contains 5-methoxyuridine (5-moU) modified nucleotides, which decreases immunogenicity, enhances mRNA stability, and increases translational efficiency, resulting in more reliable and reproducible protein yield.

Description

mRNA Length 996 nucleotides
Concentration1 mg/mL
Buffer 1 mM Sodium Citrate, pH 6.4 Storage -40°C or below
General tipsDissolve it on ice and take care to prevent RNase contamination degradation. Avoid repeated freezing and thawing as much as possible. Do not vortex. For the first time, it is gently centrifuged and divided into several parts for stand-alone use. Use RNase-free reagents and consumables, using appropriate RNase-free technology. It can not be added to the serum-containing medium until it is mixed with the transfection reagent.
Shipping Conditionship with dry ice.

Product Citation

Quality Control

Quality Control & Datasheet

View current batch:

Related Biological Data

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Related Biological Data

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Related Biological Data

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Related Biological Data

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Related Biological Data

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Related Biological Data

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Related Biological Data

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)

Related Biological Data

EZ Cap™ Cy5 EGFP mRNA (5-moUTP)